Effects of Atomoxetine on Hyper-Locomotive Activity of the Prenatally Valproate-Exposed Rat Offspring |
Choi, Chang Soon
(Department of Neuroscience and Center for Neuroscience Research, SMART Institute of Advanced Biomedical Sciences)
Hong, Minha (Department of Psychiatry, School of Medicine, Dankook University Hospital) Kim, Ki Chan (Department of Neuroscience and Center for Neuroscience Research, SMART Institute of Advanced Biomedical Sciences) Kim, Ji-Woon (Department of Neuroscience and Center for Neuroscience Research, SMART Institute of Advanced Biomedical Sciences) Yang, Sung Min (Department of Neuroscience and Center for Neuroscience Research, SMART Institute of Advanced Biomedical Sciences) Seung, Hana (Department of Neuroscience and Center for Neuroscience Research, SMART Institute of Advanced Biomedical Sciences) Ko, Mee Jung (Department of Neuroscience and Center for Neuroscience Research, SMART Institute of Advanced Biomedical Sciences) Choi, Dong-Hee (Department of Neuroscience and Center for Neuroscience Research, SMART Institute of Advanced Biomedical Sciences) You, Jueng Soo (Department of Neuroscience and Center for Neuroscience Research, SMART Institute of Advanced Biomedical Sciences) Shin, Chan Young (Department of Neuroscience and Center for Neuroscience Research, SMART Institute of Advanced Biomedical Sciences) Bahn, Geon Ho (Department of Neuropsychiatry, School of Medicine, Kyung Hee University) |
1 | Ali, E. H. and Elgoly, A. H. (2013) Combined prenatal and postnatal butyl paraben exposure produces autism-like symptoms in offspring: Comparison with valproic acid autistic model. Pharmacol. Biochem. Behav. 111, 102-110. DOI |
2 | Baf, M. H., Subhash, M. N., Lakshmana, K. M. and Rao, B. S. (1994) Sodium valproate induced alterations in monoamine levels in different regions of the rat brain. Neurochem. Int. 24, 67-72. DOI ScienceOn |
3 | Banerjee, S., Riordan, M. and Bhat, M. (2014) Genetic aspects of autism spectrum disorders: insights from animal models. Front. Cell. Neurosci. 8, 58. |
4 | Barr, A. M., Lehmann-Masten, V., Paulus, M., Gainetdinov, R. R., Caron, M. G. and Geyer, M. A. (2004) The selective serotonin-2A receptor antagonist M100907 reverses behavioral deficits in dopamine transporter knockout mice. Neuropsychopharmacology 29, 221-228. DOI |
5 | Bayles, R., Baker, E., Eikelis, N., El-Osta, A. and Lambert, G. (2010) Histone modifications regulate the norepinephrine transporter gene. Cell Cycle 9, 4600-4601. DOI |
6 | Biederman, J. and Spencer, T. (1999) Attention-deficit/hyperactivity disorder (ADHD) as a noradrenergic disorder. Biol. Psychiatry 46, 1234-1242. DOI ScienceOn |
7 | Boy, F., Evans, C. J., Edden, R. A., Lawrence, A. D., Singh, K. D., Husain, M. and Sumner, P. (2011) Dorsolateral prefrontal gammaaminobutyric acid in men predicts individual differences in rash impulsivity. Biol. Psychiatry 70, 866-872. DOI |
8 | Bymaster, F. P., Katner, J. S., Nelson, D. L., Hemrick-Luecke, S. K., Threlkeld, P. G., Heiligenstein, J. H., Morin, S. M., Gehlert, D. R. and Perry, K. W. (2002) Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat: a potential mechanism for efficacy in attention deficit/hyperactivity disorder. Neuropsychopharmacology 27, 699-711. DOI ScienceOn |
9 | Christianson, A. L., Chesler, N. and Kromberg, J. G. (1994) Fetal valproate syndrome: clinical and neuro-developmental features in two sibling pairs. Dev. Med. Child Neurol. 36, 361-369. |
10 | Consortium. (1994) Fmr1 knockout mice: a model to study fragile X mental retardation. Cell 78, 23-33. |
11 | Edden, R. A., Crocetti, D., Zhu, H., Gilbert, D. L. and Mostofsky, S. H. (2012) Reduced GABA concentration in attention-deficit/hyperactivity disorder. Arch. Gen. Psychiatry 69, 750-753. |
12 | Flores, J. A., Galan-Rodriguez, B., Ramiro-Fuentes, S. and Fernandez-Espejo, E. (2006) Role for dopamine neurons of the rostral linear nucleus and periaqueductal gray in the rewarding and sensitizing properties of heroin. Neuropsychopharmacology 31, 1475-1488. DOI |
13 | Gadow, K. D., Devincent, C. J., Pomeroy, J. and Azizian, A. (2005) Comparison of DSM-IV symptoms in elementary school-age children with PDD versus clinic and community samples. Autism 9, 392-415. DOI |
14 | Gatley, S. J., Pan, D., Chen, R., Chaturvedi, G. and Ding, Y. S. (1996) Affinities of methylphenidate derivatives for dopamine, norepinephrine and serotonin transporters. Life Sci. 58, 231-239. |
15 | Han, H., Ma, Y., Eun, J. S., Hong, J. T. and Oh, K. W. (2008) Anxiolyticlike effects of cyclopeptide fraction alkaloids of Zizyphi Spinosi semen: possible involvement of GABAA receptors. Biomol. Ther. 16, 261-269. DOI |
16 | Kim, K. C., Lee, D. K., Go, H. S., Kim, P., Choi, C. S., Kim, J. W., Jeon, S. J., Song, M. R. and Shin, C. Y. (2014) Pax6-dependent cortical glutamatergic neuronal differentiation regulates autism-like behavior in prenatally valproic acid-exposed rat offspring. Mol. Neurobiol. 49, 512-528. DOI |
17 | Hunt, R. D., Arnsten, A. F. and Asbell, M. D. (1995) An open trial of guanfacine in the treatment of attention-deficit hyperactivity disorder. J. Am. Acad. Child Adolesc. Psychiatry 34, 50-54. DOI |
18 | Jaselskis, C. A., Cook, E. H., JR., Fletcher, K. E. and Leventhal, B. L. (1992) Clonidine treatment of hyperactive and impulsive children with autistic disorder. J. Clin. Psychopharmacol. 12, 322-327. |
19 | Kim, K. C., Kim, P., Go, H. S., Choi, C. S., Park, J. H., Kim, H. J., Jeon, S. J., Dela Pena, I. C., Han, S. H., Cheong, J. H., Ryu, J. H. and Shin, C. Y. (2013) Male-specific alteration in excitatory postsynaptic development and social interaction in pre-natal valproic acid exposure model of autism spectrum disorder. J. Neurochem. 124, 832-843. DOI ScienceOn |
20 | Lempp, T., Toennes, S. W., Wunder, C., Russe, O. Q., Moser, C. V., Kynast, K. L., Freitag, C. M. and Niederberger, E. (2013) Altered gene expression in the prefrontal cortex of young rats induced by the ADHD drug atomoxetine. Prog. Neuropsychopharmacol. Biol. Psychiatry 40, 221-228. |
21 | Leyfer, O. T., Folstein, S. E., Bacalman, S., Davis, N. O., Dinh, E., Morgan, J., Tager-Flusberg, H. and Lainhart, J. E. (2006) Comorbid psychiatric disorders in children with autism: interview development and rates of disorders. J. Autism Dev. Disord. 36, 849-861. DOI |
22 | Ludolph, A. G., Udvardi, P. T., Schaz, U., Henes, C., Adolph, O., Weigt, H. U., Fegert, J. M., Boeckers, T. M. and Fohr, K. J. (2010) Atomoxetine acts as an NMDA receptor blocker in clinically relevant concentrations. Br. J. Pharmacol. 160, 283-291. DOI |
23 | Shaywitz, B. A., Yager, R. D. and Klopper, J. H. (1976) Selective brain dopamine depletion in developing rats: an experimental model of minimal brain dysfunction. Science 191, 305-308. DOI |
24 | Russell, V., De Villiers, A., Sagvolden, T., Lamm, M. and Taljaard, J. (1995) Altered dopaminergic function in the prefrontal cortex, nucleus accumbens and caudate-putamen of an animal model of attention-deficit hyperactivity disorder--the spontaneously hypertensive rat. Brain Res. 676, 343-351. DOI |
25 | Schneider, T. and Przewlocki, R. (2005) Behavioral alterations in rats prenatally exposed to valproic acid: animal model of autism. Neuropsychopharmacology 30, 80-89. DOI ScienceOn |
26 | Schneider, T., Ziolkowska, B., Gieryk, A., Tyminska, A. and Przewlocki, R. (2007) Prenatal exposure to valproic acid disturbs the enkephalinergic system functioning, basal hedonic tone, and emotional responses in an animal model of autism. Psychopharmacology (Berl), 193, 547-555. DOI |
27 | Simonoff, E., Pickles, A., Charman, T., Chandler, S., Loucas, T. and Baird, G. (2008) Psychiatric disorders in children with autism spectrum disorders: prevalence, comorbidity, and associated factors in a population-derived sample. J. Am. Acad. Child Adolesc. Psychiatry 47, 921-929. DOI |
28 | Stigler, K. A., Desmond, L. A., Posey, D. J., Wiegand, R. E. and Mcdougle, C. J. (2004) A naturalistic retrospective analysis of psychostimulants in pervasive developmental disorders. J. Child Adolesc. Psychopharmacol. 14, 49-56. DOI |
29 | Sumner, P., Edden, R. A., Bompas, A., Evans, C. J. and Singh, K. D. (2010) More GABA, less distraction: a neurochemical predictor of motor decision speed. Nat. Neurosci. 13, 825-827. DOI |
30 | Ma, C. L., Arnsten, A. F. and Li, B. M. (2005) Locomotor hyperactivity induced by blockade of prefrontal cortical alpha2-adrenoceptors in monkeys. Biol. Psychiatry 57, 192-195. DOI ScienceOn |
31 | Masuo, Y., Ishido, M., Morita, M., Sawa, H., Nagashima, K. and Niki, E. (2007) Behavioural characteristics and gene expression in the hyperactive wiggling (Wig) rat. Eur. J. Neurosci. 25, 3659-3666. DOI |
32 | Munarriz, R., Bennett, L. and Goldstein, I. (2002) Risperidone in children with autism and serious behavioral problems. N. Engl. J. Med. 347, 1890-1891; author reply 1890-1891. DOI |
33 | Narita, N., Kato, M., Tazoe, M., Miyazaki, K., Narita, M. and Okado, N. (2002) Increased monoamine concentration in the brain and blood of fetal thalidomide-and valproic acid-exposed rat: putative animal models for autism. Pediatr. Res. 52, 576-579. |
34 | Nelson, J. D., Denisenko, O. and Bomsztyk, K. (2006) Protocol for the fast chromatin immunoprecipitation (ChIP) method. Nat. Protoc. 1, 179-185. DOI |
35 | Pandolfo, P., Machado, N. J., Kofalvi, A., Takahashi, R. N. and Cunha, R. A. (2013) Caffeine regulates frontocorticostriatal dopamine transporter density and improves attention and cognitive deficits in an animal model of attention deficit hyperactivity disorder. Eur. Neuropsychopharmacol. 23, 317-328. DOI |
36 | Phiel, C. J., Zhang, F., Huang, E. Y., Guenther, M. G., Lazar, M. A. and Klein, P. S. (2001) Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen. J. Biol. Chem. 276, 36734-36741. DOI ScienceOn |
37 | Rinaldi, T., Kulangara, K., Antoniello, K. and Markram, H. (2007) Elevated NMDA receptor levels and enhanced postsynaptic long-term potentiation induced by prenatal exposure to valproic acid. Proc. Natl. Acad. Sci. U.S.A. 104, 13501-13506. DOI ScienceOn |
38 | Wilkins, J. and Matson, J. L. (2009) A comparison of social skills profiles in intellectually disabled adults with and without ASD. Behav. Modif. 33, 143-155. DOI |
39 | Vizi, E. S., Zsilla, G., Caron, M. G. and Kiss, J. P. (2004) Uptake and release of norepinephrine by serotonergic terminals in norepinephrine transporter knock-out mice: implications for the action of selective serotonin reuptake inhibitors. J. Neurosci. 24, 7888-7894. DOI |
40 | Watanabe, Y., Fujita, M., Ito, Y., Okada, T., Kusuoka, H. and Nishimura, T. (1997) Brain dopamine transporter in spontaneously hypertensive rats. J. Nucl. Med. 38, 470-474. |
41 | Williams, G., King, J., Cunningham, M., Stephan, M., Kerr, B. and Hersh, J. H. (2001) Fetal valproate syndrome and autism: additional evidence of an association. Dev. Med. Child Neurol. 43, 202-206. DOI |
42 | Wong, D. T., Threlkeld, P. G., Best, K. L. and Bymaster, F. P. (1982) A new inhibitor of norepinephrine uptake devoid of affinity for receptors in rat brain. J. Pharmacol. Exp. Ther. 222, 61-65. |
43 | Yamashita, M., Fukushima, S., Shen, H. W., Hall, F. S., Uhl, G. R., Numachi, Y., Kobayashi, H. and Sora, I. (2006) Norepinephrine transporter blockade can normalize the prepulse inhibition deficits found in dopamine transporter knockout mice. Neuropsychopharmacology 31, 2132-2139. |
44 | Young, J. G., Kavanagh, M. E., Anderson, G. M., Shaywitz, B. A. and Cohen, D. J. (1982) Clinical neurochemistry of autism and associated disorders. J. Autism Dev. Disord. 12, 147-165. DOI |
45 | Zhang, S. J., Huguenard, J. R. and Prince, D. A. (1997) GABAA receptor-mediated Cl-currents in rat thalamic reticular and relay neurons. J. Neurophysiol. 78, 2280-2286. DOI |
46 | Research Units on Pediatric Psychopharmacology Autism Network. (2005) Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity. Arch. Gen. Psychiatry 62, 1266-1274. DOI |
47 | Barr, C. L., Wigg, K., Zai, G., Roberts, W., Malone, M., Schachar, R., Tannock, R. and Kennedy, J. L. (2001) Attention-deficit hyperactivity disorder and the adrenergic receptors alpha 1C and alpha 2C. Mol. Psychiatry 6, 334-337. DOI ScienceOn |
48 | Challman, T. D. and Lipsky, J. J. (2000) Methylphenidate: its pharmacology and uses. Mayo Clin. Proc. 75, 711-721. DOI |
49 | Lipska, B. K., Jaskiw, G. E. and Weinberger, D. R. (1993) Postpubertal emergence of hyperresponsiveness to stress and to amphetamine after neonatal excitotoxic hippocampal damage: a potential animal model of schizophrenia. Neuropsychopharmacology 9, 67-75. DOI ScienceOn |
50 | Xu, F., Gainetdinov, R. R., Wetsel, W. C., Jones, S. R., Bohn, L. M., Miller, G. W., Wang, Y. M. and Caron, M. G. (2000) Mice lacking the norepinephrine transporter are supersensitive to psychostimulants. Nat. Neurosci. 3, 465-471. DOI |